Amgen

aid: amgen
url: https://raw.githubusercontent.com/api-evangelist/amgen/refs/heads/main/apis.yml
name: Amgen
description: Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering,
  developing, manufacturing and delivering innovative human therapeutics. As a pioneer in biotechnology since 1980, Amgen
  uses living cells to make biologic medicines addressing cardiovascular metabolic conditions, oncology, inflammation, rare
  diseases, and bone health, operating in approximately 100 countries worldwide.
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/apis-json-logo.jpg
tags:
- Biotechnology
- Biopharmaceutical
- Oncology
- Inflammation
- Cardiovascular
- Rare Disease
- Biosimilars
- Life Sciences
- Fortune 500
created: '2024-01-01'
modified: '2026-04-19'
specificationVersion: '0.18'
apis:
- aid: amgen:website
  name: Amgen Website
  tags:
  - Biotechnology
  - Biopharmaceutical
  - Life Sciences
  image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/apis-json-logo.jpg
  baseURL: https://www.amgen.com
  humanURL: https://www.amgen.com
  properties:
  - type: Website
    url: https://www.amgen.com
  description: Amgen discovers, develops, manufactures, and delivers innovative biologic medicines for patients with serious
    illnesses. The company does not currently publish a public developer API.
common:
- type: GitHubOrganization
  url: https://github.com/Amgen
- type: Portal
  url: https://www.amgen.com
- type: Blog
  url: https://www.amgen.com/stories
- type: PrivacyPolicy
  url: https://www.amgen.com/privacy-statement
- type: TermsOfService
  url: https://www.amgen.com/terms-of-use
- type: Support
  url: https://www.amgen.com/contact-amgen
- type: LinkedIn
  url: https://www.linkedin.com/company/amgen
- type: X
  url: https://twitter.com/AmgenNews
- type: YouTube
  url: https://www.youtube.com/amgen
- type: Features
  data:
  - name: Biologic Drug Discovery
    description: Pioneering use of living cells and human genetic data combined with AI and generative biology to discover
      novel biologic medicines.
  - name: Oncology Therapeutics
    description: Cancer medicines targeting solid tumors and hematologic malignancies including innovative BiTE and antibody
      therapies.
  - name: Cardiovascular and Metabolic Medicines
    description: Medicines addressing heart disease, high cholesterol (Lp(a)), obesity, and obesity-related metabolic conditions.
  - name: Inflammation Therapeutics
    description: Treatments for inflammatory conditions including chronic rhinosinusitis with nasal polyps, asthma, and other
      immune-mediated diseases.
  - name: Rare Disease Medicines
    description: Therapies for rare conditions including IgG4-related disease (IgG4-RD), generalized myasthenia gravis, and
      other orphan indications.
  - name: Bone Health Products
    description: Medicines for osteoporosis, bone metastases, and other bone health conditions including PROLIA and XGEVA.
  - name: Biosimilars
    description: High-quality biosimilar medicines providing more affordable alternatives to reference biologic therapies
      across multiple therapeutic areas.
  - name: AI-Driven Drug Development
    description: Application of artificial intelligence, generative biology, and advanced data science to accelerate drug
      discovery and clinical trial optimization.
- type: UseCases
  data:
  - name: Cancer Treatment
    description: Providing oncology medicines for patients with solid tumors and blood cancers through innovative biologic
      and targeted therapies.
  - name: Heart Disease Prevention
    description: Reducing cardiovascular risk with medicines targeting LDL cholesterol, Lp(a), and other cardiovascular risk
      factors.
  - name: Inflammatory Disease Management
    description: Managing chronic inflammatory conditions with targeted biologic therapies for patients with severe unmet
      medical needs.
  - name: Rare Disease Treatment
    description: Delivering life-changing therapies to patients with rare and ultra-rare diseases where few or no other treatments
      exist.
  - name: Biosimilar Access
    description: Improving patient access to biologic therapies through high-quality, lower-cost biosimilar medicines.
  - name: Weight Management
    description: Addressing obesity and obesity-related conditions with novel medicines targeting metabolic pathways.
- type: Integrations
  data:
  - name: Amgen SupportPlus
    description: Patient support program providing financial assistance, insurance navigation, and access services for Amgen
      medicines.
  - name: Clinical Trials Network
    description: Global clinical research network conducting Phase I through Phase III trials across therapeutic areas with
      AI-optimized trial design.
  - name: Amgen Biosimilars
    description: Portfolio of biosimilar medicines offered through partnerships with healthcare systems globally to improve
      treatment access.
- type: Integrations
  url: https://www.amgen.com/partners
integrations:
- name: Academic Collaborations
- name: Suppliers
- name: Wholesalers
maintainers:
- FN: API Evangelist
  email: info@apievangelist.com